Grundläggande statistik
| CIK | 1847846 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to EUDA Health Holdings Limited
SEC Filings (Chronological Order)
Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.
| June 1, 2026 |
Exhibit 99.1 EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements After receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency Singapore, June 1, 2026 (Globe Newswire) - EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice (the “MVLS Notice”) from Listing Qualifications Department of The Nasd |
|
| June 1, 2026 |
Exhibit 99.1 EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask SINGAPORE, June 01, 2026 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China, today announced it is expanding the Helixé product line wit |
|
| June 1, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2026 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 (Addr |
|
| June 1, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2026 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 (Add |
|
| May 26, 2026 |
As filed with the Securities and Exchange Commission on May 26, 2026 As filed with the Securities and Exchange Commission on May 26, 2026 Registration Statement No. |
|
| May 26, 2026 |
Calculation of Filing Fee Tables F-3 EUDA Health Holdings Ltd Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial Effective Date Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to be Paid 1 Equity Ordinary Shares Other 940,657 $ 17. |
|
| April 28, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES E |
|
| April 28, 2026 |
Exhibit 99.1 EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development SINGAPORE, April 28, 2026 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China, today announced that Shenzhen Inno Immune Co., Lt |
|
| April 28, 2026 |
Exhibit 10.27 |
|
| April 28, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2026 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 (Ad |
|
| April 27, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2026 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 (Ad |
|
| April 27, 2026 |
Exhibit 99.1 EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities Singapore. April 27, 2026 (Globe Newswire) - EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice (the “MVLS Notice”) from Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) on April 23, 2026, indi |
|
| March 19, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 (Ad |
|
| March 19, 2026 |
EUDA Announces Reverse Stock Split of its Ordinary Shares Exhibit 99.1 EUDA Announces Reverse Stock Split of its Ordinary Shares SINGAPORE, March 19, 2026 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that it will implement a reverse stock split of its ordinary shares at a ratio of 1-for-20 (the |
|
| March 5, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2026 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 |
|
| March 5, 2026 |
Exhibit 3.1 |
|
| March 5, 2026 |
EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant Exhibit 99.1 EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant SINGAPORE, March 04, 2026 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that it has repurchased and cancelled in full the warrant prev |
|
| March 2, 2026 |
EUDA HEALTH HOLDINGS LIMITED Ordinary Shares Filed Pursuant to Rule 424(b)(5) Registration No. 333-282723 PROSPECTUS SUPPLEMENT (To Prospectus dated November 4, 2024) EUDA HEALTH HOLDINGS LIMITED 12,500,000 Ordinary Shares Pursuant to this Prospectus Supplement (this “Prospectus Supplement”) and the accompanying base prospectus (the “Prospectus”), as amended, we are offering in a registered direct offering 12,500,000 ordinary shares (the “Or |
|
| March 2, 2026 |
FORM OF SECURITIES PURCHASE AGREEMENT Exhibit 1.1 FORM OF SECURITIES PURCHASE AGREEMENT EUDA Health Holdings Limited 60 Kaki Bukit Place, #03-01 Eunos Techpark Singapore 415979 Ladies and Gentlemen: The undersigned (the “Purchaser”) understands that EUDA Health Holdings Limited, a British Virgin Islands business company (the “Company”), is offering an aggregate of up to ordinary shares of the Company, no par value (the “Securities”) a |
|
| March 2, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February, 2026 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 |
|
| January 23, 2026 |
EUDA HEALTH HOLDINGS LIMITED Ordinary Shares Filed Pursuant to Rule 424(b)(5) Registration No. 333-282723 PROSPECTUS SUPPLEMENT (To Prospectus dated November 4, 2024) EUDA HEALTH HOLDINGS LIMITED $10,000,000 Ordinary Shares We entered into an At The Market Offering Agreement (the “Sales Agreement”) dated June 23, 2025 with Chardan Capital Markets, LLC (“Chardan” or “Agent”), relating to our ordinary shares offered by the prospectus dated Nov |
|
| January 15, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2026 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 ( |
|
| January 15, 2026 |
EUDA Health Announces Second Amendment to Streeterville Warrant Agreement Exhibit 99.1 EUDA Health Announces Second Amendment to Streeterville Warrant Agreement SINGAPORE, Jan. 15, 2026 (GLOBE NEWSWIRE) – EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that it has entered into a second amendment to its previously disclosed warrant a |
|
| January 13, 2026 |
Filed Pursuant to Rule 424(b)(5) Registration No. 333-282723 PROSPECTUS SUPPLEMENT NO. 4 (To Prospectus dated November 4, 2024) EUDA HEALTH HOLDINGS LIMITED Convertible Warrant Up to 2,000,000 Ordinary Shares issuable upon exercise of the Warrant Pursuant to a Securities Purchase Agreement dated November 26, 2025 (the “Purchase Agreement”) between us and Streeterville Capital, LLC, a Utah limited |
|
| January 13, 2026 |
Exhibit 1.1 SECOND WARRANT AMENDMENT This Second Warrant Amendment (this “Second Amendment”) is entered into as of January 13, 2026 (the “Effective Date”), by and between Streeterville Capital, LLC, a Utah limited liability Company (“Investor”), and EUDA Health Holdings Limited, a British Virgin Islands exempt company (“Company”). Capitalized terms used in this Second Amendment without definition |
|
| January 13, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2026 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 ( |
|
| January 13, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2026 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 ( |
|
| January 13, 2026 |
Exhibit 99.1 EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform SINGAPORE, Jan. 13, 2026 (GLOBE NEWSWIRE) - EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that its wholly owned subsidiary, EUDA Health |
|
| January 7, 2026 |
EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement Exhibit 99.1 EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement SINGAPORE, Jan. 07, 2026 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company”, a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that it has entered into an amendment (the “Warrant Amendment”) to its p |
|
| January 7, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2026 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 ( |
|
| December 30, 2025 |
Exhibit 99.1 EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital SINGAPORE, Dec. 30, 2025 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company,” a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced the la |
|
| December 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 |
|
| December 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 |
|
| December 29, 2025 |
EUDA Health to Launch EUDA Helixé 2.0 in January 2026 Exhibit 99.1 EUDA Health to Launch EUDA Helixé 2.0 in January 2026 SINGAPORE, Dec. 29, 2025 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company”, a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that it will launch EUDA Helixé 2.0 in January 2026, marking the next generation upgrade of its premiu |
|
| December 23, 2025 |
Exhibit 99.1 EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen SINGAPORE, Dec. 23, 2025 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company”, a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced a significant acceleration of its l |
|
| December 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 |
|
| December 22, 2025 |
Exhibit 99.1 EUDA Integrates QB Utility Token to Create a Digital Health and Rewards Platform Across Its Healthcare Ecosystem SINGAPORE, Dec. 22, 2025 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company”, a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced a strategic technology integration that wou |
|
| December 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 |
|
| December 19, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 |
|
| December 19, 2025 |
Filed Pursuant to Rule 424(b)(5) Registration No. 333-282723 PROSPECTUS SUPPLEMENT NO. 3 (To Prospectus dated November 4, 2024) EUDA HEALTH HOLDINGS LIMITED Convertible Warrant Up to 2,000,000 Ordinary Shares issuable upon exercise of the Warrant Pursuant to a Securities Purchase Agreement dated November 26, 2025 (the “Purchase Agreement”) between us and Streeterville Capital, LLC, a Utah limited |
|
| December 19, 2025 |
Exhibit 1.1 |
|
| December 8, 2025 |
EUDA Plans to Integrate QB Utility Token into Its Healthcare Ecosystem Exhibit 99.1 EUDA Plans to Integrate QB Utility Token into Its Healthcare Ecosystem SINGAPORE, Dec. 08, 2025 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based leading non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced its plans to create an integrated digital health and rewards platform which |
|
| December 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 |
|
| December 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 |
|
| December 5, 2025 |
EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement Exhibit 99.1 EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement SINGAPORE, Dec. 05, 2025 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or “the Company”), a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that it entered into a securities purchase agreement on November 26, 202 |
|
| December 4, 2025 |
WARRANT TO PURCHASE ORDINARY SHARES Exhibit 1.2 WARRANT TO PURCHASE ORDINARY SHARES 1. Issuance. For good and valuable consideration as set forth in the Purchase Agreement (as defined below), including without limitation the Purchase Price (as defined in the Purchase Agreement), the receipt and sufficiency of which are hereby acknowledged by EUDA Health Holdings Limited, a British Virgin Islands exempt company (“Company”); Streeterv |
|
| December 4, 2025 |
Exhibit 1.1 Securities Purchase Agreement This Securities Purchase Agreement (this “Agreement”), dated as of November 26, 2025, is entered into by and between EUDA Health Holdings Limited, a British Virgin Islands exempt company (“Company”), and Streeterville Capital, LLC, a Utah limited liability company, its successors and/or assigns (“Investor”). A. Company and Investor are executing and delive |
|
| December 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 |
|
| December 4, 2025 |
Filed Pursuant to Rule 424(b)(5) Registration No. 333-282723 PROSPECTUS SUPPLEMENT (To Prospectus dated November 4, 2024) EUDA HEALTH HOLDINGS LIMITED Convertible Warrant Up to 2,000,000 Ordinary Shares issuable upon exercise of the Warrant We are offering, in a registered direct offering to Streeterville Capital, LLC, a Utah limited liability company and an accredited investor (the “Investor”), a |
|
| November 18, 2025 |
Filed Pursuant to Rule 424(b)(5) Registration No. 333-282723 PROSPECTUS SUPPLEMENT NO. 2 (To Prospectus dated November 4, 2024) EUDA HEALTH HOLDINGS LIMITED We previously entered into a Convertible Promissory Note Purchase Agreement (the “Purchase Agreement”), dated August 1, 2025, which was amended on each of September 19, 2025, October 2, 2025 and November 7, 2025, with Indigo Capital LP, an acc |
|
| November 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 |
|
| November 17, 2025 |
Exhibit 1.1 November 7, 2025 Mr. George Sandhu Managing Director Indigo Capital LP 89 Nexus Way Caymana Bay, Cayman Islands Re: August 1, 2025 EUDA Health Holdings Ltd. (the “Company”) Promissory Note (the “Note”) and August 1, 2025 Convertible Promissory Note Agreement (the “Agreement”) between Indigo Capital, LP (“Indigo”) and the Company. Dear Mr. Sandhu: I write to confirm our third amendment |
|
| October 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 ( |
|
| October 23, 2025 |
EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India Exhibit 99.1 EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India SINGAPORE, Oct. 23, 2025 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that its wholly-owned subsidiary, CK Health Plus Sdn. Bhd. |
|
| October 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 ( |
|
| October 20, 2025 |
Exhibit 99.1 EUDA Subsidiary CK Health Plus Secures Malaysia Direct Selling License, Strengthening Its Longevity Business Across Asia SINGAPORE, Oct. 20, 2025 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that its wholly-owned subsidiary, |
|
| October 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 ( |
|
| October 3, 2025 |
Exhibit 1.1 |
|
| October 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 ( |
|
| October 1, 2025 |
Exhibit 99.2 OPERATING AND FINANCIAL REVIEW AND PROSPECTS IN CONNECTION WITH THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2025 AND 2024 In this report, as used herein, and unless the context suggests otherwise, the terms “EUDA,” “Company,” “we,” “us” or “ours” refer to the combined business of Euda Health Holdings Limited and its subsidiaries |
|
| October 1, 2025 |
EUDA HEALTH HOLDINGS LIMITED AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS Exhibit 99.1 EUDA HEALTH HOLDINGS LIMITED AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS June 30, December 31, 2025 2024 ASSETS CURRENT ASSETS Cash $ 176,584 $ 237,605 Accounts receivable, net 426,688 146,174 Inventories 116,845 128,977 Other receivables 50,841 4,596 Other receivable, related party 20,698 19,497 Other receivable 20,698 19,497 Prepaid expenses and other current as |
|
| October 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 ( |
|
| September 25, 2025 |
September 25, 2025 Alfred Lim Chief Executive Officer EUDA Health Holdings Ltd 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 Re: EUDA Health Holdings Ltd Form 20-F for Fiscal Year Ended December 31, 2024 File No. |
|
| September 24, 2025 |
EUDA Health Holdings Ltd 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 EUDA Health Holdings Ltd 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 September 24, 2025 Via Edgar United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services Washington, DC 20549 Attention: Tayyaba Shafique and Terence O’Brien Re: EUDA Health Holdings Ltd Amendment No. |
|
| September 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A (Amendment No. 2) (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) |
|
| September 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 |
|
| September 22, 2025 |
Exhibit 1.1 September 19, 2025 George Sandhu Managing Director Indigo Capital LP 89 Nexus Way Caymana Bay, Cayman Islands Re: August 1, 2025 EUDA Health Holdings Ltd. (the “Company”) Promissory Note (the “Note”) and August 1, 2025 Convertible Promissory Note Agreement between Indigo Capital, LP (“Indigo”) and the Company. Dear Mr. Sandhu: Thank you for taking the time to speak with Vivian Tay earl |
|
| September 17, 2025 |
September 17, 2025 Alfred Lim Chief Executive Officer EUDA Health Holdings Ltd 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 Re: EUDA Health Holdings Ltd Amendment No. |
|
| September 11, 2025 |
EUDA Health Holdings Ltd 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 EUDA Health Holdings Ltd 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 September 11, 2025 Via Edgar United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services Washington, DC 20549 Attention: Tayyaba Shafique and Terence O’Brien Re: EUDA Health Holdings Ltd Form 20-F for Fiscal Year Ended December 31, 2024 File No. |
|
| September 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F/A (Amendment No. 1) (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) |
|
| September 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 |
|
| September 10, 2025 |
EUDA Signs Letter of Intent to Potentially Acquire GO POSB Exhibit 99.1 EUDA Signs Letter of Intent to Potentially Acquire GO POSB SINGAPORE, Sept. 10, 2025 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that its wholly-owned subsidiary, EUDA Health Pte. Ltd. (“EUDA Health”), has signed a Letter o |
|
| September 4, 2025 |
EUDA Strategically Expands into T-Cell Immunotherapy – Strengthening Its Stem Cell Therapy Portfolio Exhibit 99.1 EUDA Strategically Expands into T-Cell Immunotherapy – Strengthening Its Stem Cell Therapy Portfolio SINGAPORE, Sept. 04, 2025 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a leading Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China, today announced that it has secured distribution rights |
|
| September 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 |
|
| August 29, 2025 |
August 29, 2025 Alfred Lim Chief Executive Officer EUDA Health Holdings Ltd 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 Re: EUDA Health Holdings Ltd Form 20-F for Fiscal Year Ended December 31, 2024 File No. |
|
| August 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979. ( |
|
| August 28, 2025 |
EUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte Ltd Exhibit 99.1 EUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte Ltd SINGAPORE, Aug. 28, 2025 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a leading Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that it has signed a Letter of Intent (the “LOI”) to potentially acquire Chem |
|
| August 26, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-06 One Pemimpin Singapore 576151 (Address |
|
| August 26, 2025 |
EUDA Expands Wellness Product Portfolio With A Next-Generation Immune Health Supplement Exhibit 99.1 EUDA Expands Wellness Product Portfolio With A Next-Generation Immune Health Supplement SINGAPORE, Aug. 26, 2025 (GLOBE NEWSWIRE) - EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a leading Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that its wholly-owned subsidiary, EUDA Health Pte. Ltd., h |
|
| August 8, 2025 |
Filed Pursuant to Rule 424(b)(5) Registration No. 333-282723 PROSPECTUS SUPPLEMENT (To Prospectus dated November 4, 2024) EUDA HEALTH HOLDINGS LIMITED US$10,000,000 Convertible Note Up to 5,000,000 Ordinary Shares issuable upon conversion of the $10,000,000 Convertible Note We are offering, in a registered direct offering to Indigo Capital LP, an accredited investor (the “Investor”), one or more c |
|
| August 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K/A Amendment No. 1 REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark Si |
|
| August 6, 2025 |
Exhibit 1.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark Singapore 415979 (Ad |
|
| August 6, 2025 |
EUDA HEALTH HOLDINGS LTD. CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENT Exhibit 1.1 EUDA HEALTH HOLDINGS LTD. CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENT This CONVERTIBLE PROMISSORY NOTE PURCHASE AGREEMENT (this “Agreement”) is made as of August 1, 2025, by and between EUDA HEALTH HOLDINGS LTD., a company organized under the laws of British Virgin Islands (the “Company”), and Indigo Capital LP, a limited partnership organized under the laws of the Cayman Islands (t |
|
| June 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark Singapore 415979 (Addr |
|
| June 24, 2025 |
AT THE MARKET OFFERING AGREEMENT June 23, 2025 Exhibit 1.1 AT THE MARKET OFFERING AGREEMENT June 23, 2025 Chardan Capital Markets 1 Pennsylvania Plaza Suite 4800 New York, NY 10119 Ladies and Gentlemen: EUDA Health Holdings Limited, a corporation organized under the laws of the British Virgin Islands (the “Company”), confirms its agreement (this “Agreement”) with Chardan Capital Markets LLC (the “Sole Manager” or “Manager”) Definitions. The te |
|
| June 24, 2025 |
EUDA HEALTH HOLDINGS LIMITED Ordinary Shares FILED PURSUANT TO RULE 424(b)(5) REGISTRATION NO. 333-282723 PROSPECTUS SUPPLEMENT (to Prospectus dated November 4, 2024) $10,000,000 EUDA HEALTH HOLDINGS LIMITED Ordinary Shares We entered into an At The Market Offering Agreement (the “Sales Agreement”) dated June 23, 2025 with Chardan Capital Markets, LLC (“Chardan” or “Agent”), relating to our ordinary shares offered by this prospectus suppleme |
|
| June 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark Singapore 415979 (Addre |
|
| April 29, 2025 |
Exhibit 10.22 DATED THIS DAY OF Between 8i Enterprises Pte Ltd (the “Lender”) And EUDA Health Holdings Limited (the “Borrower”) LOAN AGREEMENT This LOAN AGREEMENT is made the day of BETWEEN:- (1) 8I Enterprises Pte Ltd, a company incorporated in Singapore and having its office at 6, Eu Tong Sen Street, #08-13 The Central, Singapore 059817 (hereinafter referred to as “Lender’ (the “Lender”); and (2 |
|
| April 29, 2025 |
Exhibit 4.1 EUDA HEALTH HOLDINGS LIMITED Insider Trading Policy and Guidelines with Respect to Certain Transactions in Company Securities This Policy provides guidelines to employees, executive officers and directors of, and consultants and contractors to EUDA Health Holdings Limited (the “Company”) with respect to transactions in the Company’s securities. Applicability of Policy This Policy appli |
|
| April 29, 2025 |
Exhibit 10.23 LOAN EXTENSION AGREEMENT This LOAN EXTENSION AGREEMENT is made the 1st day of April 2025 BETWEEN: (1) LIM ALFRED (NRIC No. S0028833J) of 10 Marlene Avenue, Singapore 556622 (hereinafter referred to as the “Creditor”); and (2) EUDA HEALTH HOLDINGS LIMITED, a company incorporated in the British Virgin Islands and having its registered office at Clarence Thomas Building, P.O. Box 4649, |
|
| April 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES E |
|
| April 29, 2025 |
Exhibit 10.24 LOAN EXTENSION AGREEMENT This LOAN EXTENSION AGREEMENT is made the 1st day of April 2025 BETWEEN: (1) 8I ENTERPRISES PTE LTD, a company incorporated in Singapore and having its office at 6, Eu Tong Sen Street, #08-13 The Central, Singapore 059817 (hereinafter referred to as the “Creditor”); and (2) EUDA HEALTH HOLDINGS LIMITED, a company incorporated in the British Virgin Islands and |
|
| April 29, 2025 |
EUDA HEALTH HOLDINGS LIMITED CLAWBACK POLICY Exhibit 97 EUDA HEALTH HOLDINGS LIMITED CLAWBACK POLICY Introduction The Board of Directors (the “Board”) of EUDA Health Holdings Limited (formerly known as 8i Acquisition 2 Corp. |
|
| April 29, 2025 |
Exhibit 10.21 DATED THIS th day of Between Lim Alfred (the “Lender”) And EUDA Health Holdings Limited (the “Borrower”) LOAN AGREEMENT This LOAN AGREEMENT is made the day of BETWEEN:- (1) LIM ALFRED (NRIC No. S0028833J) of 10 Marlene Avenue Singapore 556622 (the “Lender”); and (2) EUDA Health HOLDINGS Limited, a company incorporated in the British Virgin Islands and having its registered office at |
|
| April 29, 2025 |
Exhibit 10.25 |
|
| April 29, 2025 |
Exhibit 10.20 THIS SUPPLEMENTAL AGREEMENT is made on 30th day of June 2024 BETWEEN: 1. LIM ALFRED (NRIC No. S0028833J) of 10 Marlene Avenue, Singapore 556622 (the “Lender”); and 2. EUDA HEALTH HOLDINGS LIMITED (Company Number 2053029), a company incorporated in the British Virgin Islands and having its registered office at Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin |
|
| April 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 (Ad |
|
| April 24, 2025 |
Exhibit 10.1 |
|
| April 24, 2025 |
Exhibit 99.1 EUDA Partners with Authorized Distributor of Guangdong Cell Biotech to Offer Stem Cell Therapies to Customers in Singapore and Malaysia April 24, 2025 07:00 ET | Source: EUDA Health Holdings Ltd SINGAPORE, April 24, 2025 (GLOBE NEWSWIRE) – EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based property management services provider and a leading non-in |
|
| April 24, 2025 |
Exhibit 10.2 |
|
| February 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 60 Kaki Bukit Place #03-01 Eunos Techpark, Singapore 415979 ( |
|
| December 16, 2024 |
Exhibit 99.1 EUDA Holdings and Guangdong Cell Biotech Explore Potential Strategic Partnership to Advance Biotechnology Innovation - Preliminary Discussions Underway to Establish a Joint Venture SINGAPORE, December 16, 2024 /Globenewswire/ — EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast |
|
| December 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-06 One Pemimpin Singapore 576151 (Addres |
|
| October 31, 2024 |
EUDA HEALTH HOLDINGS LIMITED 1 Pemimpin Drive #12-06 One Pemimpin Singapore 576151 EUDA HEALTH HOLDINGS LIMITED 1 Pemimpin Drive #12-06 One Pemimpin Singapore 576151 October 31, 2024 VIA EDGAR U. |
|
| October 30, 2024 |
As filed with the Securities and Exchange Commission on October 30, 2024 As filed with the Securities and Exchange Commission on October 30, 2024 Registration Statement No. |
|
| October 25, 2024 |
October 25, 2024 Wei Wen Kelvin Chen Chief Executive Officer EUDA Health Holdings Limited 1 Pemimpin Drive #12-06 One Pemimpin Singapore 576151 Re: EUDA Health Holdings Limited Registration Statement on Form F-3 Filed October 18, 2024 File No. |
|
| October 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-06 One Pemimpin Singapore 576151 (Address |
|
| October 18, 2024 |
As filed with the Securities and Exchange Commission on October 18, 2024 As filed with the Securities and Exchange Commission on October 18, 2024 Registration Statement No. |
|
| October 18, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form F-3 (Form Type) EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price(3) Fee Rate Amount of Re |
|
| October 18, 2024 |
EUDA HEALTH HOLDINGS LIMITED AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS Exhibit 99.1 EUDA HEALTH HOLDINGS LIMITED AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS June 30, December 31, 2024 2023 ASSETS CURRENT ASSETS Cash $ 376,206 $ 189,005 Accounts receivable, net 176,988 237,474 Prepayments 150,966 - Other receivables 19,293 1,711 Other receivable, related party 20,557 - Other receivable 20,557 - Prepaid expenses and other current assets 207,358 192 |
|
| October 18, 2024 |
EUDA HEALTH HOLDINGS LIMITED Dated as of ________, 20__ Debt Securities TABLE OF CONTENTS ARTICLE 1 Exhibit 4.7 EUDA HEALTH HOLDINGS LIMITED AND [TRUSTEE], Trustee INDENTURE Dated as of , 20 Debt Securities TABLE OF CONTENTS ARTICLE 1 ARTICLE 1 DEFINITIONS 1 Section 1.01 Definition of Terms 1 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 4 Section 2.01 Designation and Terms of Securities 4 Section 2.02 Form of Securities and Trustee’s Certificate 6 Sec |
|
| October 18, 2024 |
Exhibit 99.2 OPERATING AND FINANCIAL REVIEW AND PROSPECTS IN CONNECTION WITH THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2024 AND 2023 In this report, as used herein, and unless the context suggests otherwise, the terms “EUDA,” “Company,” “we,” “us” or “ours” refer to the combined business of Euda Health Holdings Limited and its subsidiaries |
|
| October 10, 2024 |
Exhibit 99.2 EUDA HEALTH HOLDINGS LIMITED AND SUBSIDIARIES Unaudited Pro Forma Condensed Combined Balance Sheet As of December 31, 2023 EUDA FCL Transaction Accounting Adjustments Pro Forma Combined ASSETS CURRENT ASSETS Cash $ 189,005 $ 10,812 $ - $ 199,817 Accounts receivable, net 237,474 - - 237,474 Prepaid expenses and other current assets 194,123 - - 194,123 Current assets of discontinued ope |
|
| October 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-06 One Pemimpin Singapore 576151 (Address |
|
| October 10, 2024 |
FORTRESS COVE LIMITED INDEX OF FINANCIAL STATEMENTS Exhibit 99.1 FORTRESS COVE LIMITED INDEX OF FINANCIAL STATEMENTS Financial Statements Report of Independent Registered Public Accounting Firm F-2 Consolidated Balance Sheet as of December 31, 2023 F-3 Consolidated Statement of Operations and Comprehensive Loss for the Period from November 2, 2023 (Inception) through December 31, 2023 F-4 Consolidated Statement of Changes in Shareholders’ Deficit f |
|
| September 9, 2024 |
Exhibit 16.1 September 9, 2024 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by EUDA Health Holdings Limited under Item 16.1 of its Form 6-K dated September 9, 2024. We agree with the statements concerning our Firm in such Form 6-K; we are not in a position to agree or disagree with other statements of EUDA Health Holding |
|
| September 9, 2024 |
Exhibit 10.1 |
|
| September 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 (Addre |
|
| July 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 (Address of |
|
| July 29, 2024 |
Exhibit 10.1 |
|
| July 3, 2024 |
Exhibit 10.1 |
|
| July 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 (Address of |
|
| June 26, 2024 |
Exhibit 10.1 |
|
| June 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 (Address of |
|
| May 9, 2024 |
Exhibit 2.1 DESCRIPTION OF THE COMPANY’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED General The authorized capital stock of the Company consists of an unlimited number of shares of a single class, each with no par value. No preferred shares are issued or outstanding or authorized by the Company’s Charter. Ordinary Shares The Company’s shareholde |
|
| May 9, 2024 |
EUDA HEALTH HOLDINGS LIMITED CLAWBACK POLICY Exhibit 97 EUDA HEALTH HOLDINGS LIMITED CLAWBACK POLICY Introduction The Board of Directors (the “Board”) of EUDA Health Holdings Limited (formerly known as 8i Acquisition 2 Corp. |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES |
|
| May 9, 2024 |
Exhibit 4.1 EUDA HEALTH HOLDINGS LIMITED Insider Trading Policy and Guidelines with Respect to Certain Transactions in Company Securities This Policy provides guidelines to employees, executive officers and directors of, and consultants and contractors to EUDA Health Holdings Limited (the “Company”) with respect to transactions in the Company’s securities. Applicability of Policy This Policy appli |
|
| May 8, 2024 |
Exhibit 99.1 EUDA Health Holdings Limited Completes Acquisition of CK Health Plus Sdn Bhd, Expanding into Direct Selling Holistic Wellness Products in Southeast Asia Singapore, May 08, 2024 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosyst |
|
| May 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 (Address of |
|
| May 7, 2024 |
EUDA Health Expands into Direct Selling Holistic Wellness Products with Acquisition of CK Health Exhibit 99.1 EUDA Health Expands into Direct Selling Holistic Wellness Products with Acquisition of CK Health SINGAPORE, May 6, 2024 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, today announced that it will acquire CK Health Plus S |
|
| May 7, 2024 |
[remaining of this page is intentionally left blank] Exhibit 10.1 Share Purchase Agreement BETWEEN THE PERSONS NAMED IN SCHEDULE 1 HERETO (as vendorS) AND EUDA HEALTH HOLDINGS LIMITED (as purchaser) conyers.com TABLE OF CONTENTS 1. INTERPRETATION 3 2. SALE AND PURCHASE 5 3. CONSIDERATION 5 4. conditions precedent 5 5. EARN OUT 6 6. registration rights 6 7. COMPLETION ARRANGEMENTS 7 8. REPRESENTATIONS AND WARRANTIES 8 10. Limitation on LIABILITIES 13 |
|
| May 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 (Address of |
|
| April 30, 2024 |
Exhibit 10.2 FEE SETTLEMENT AGREEMENT This Agreement (this “Agreement”), is made and entered into as of April 25, 2024, by and between EUDA Health Holdings LTD., a British Virgin Islands company (the “Company”), and Loeb & Loeb LLP, a California limited liability partnership (“Loeb”). WHEREAS, reference is made to that certain agreement, dated November 16, 2024 (the “Fee Agreement”) by and between |
|
| April 30, 2024 |
Exhibit 10.1 AGREEMENT This Agreement (this “Agreement”), is made and entered into as of November 16, 2022, by and between 8i Acquisition 2 Corp., a British Virgin Islands company (the “Company”), and Loeb & Loeb LLP, a California limited liability partnership (“Loeb”). WHEREAS, pursuant to the terms of an engagement letter executed on February 11, 2022 (the “Engagement Letter”), the Company engag |
|
| April 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 (Address o |
|
| April 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-40678 CUSIP NUMBER G3142E105 (Check one): ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tra |
|
| April 22, 2024 |
Exhibit 10.2 |
|
| April 22, 2024 |
Exhibit 10.1 |
|
| April 22, 2024 |
Exhibit 10.3 |
|
| April 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 (Address o |
|
| April 22, 2024 |
Exhibit 10.4 |
|
| April 4, 2024 |
Exhibit 10.2 |
|
| April 4, 2024 |
Exhibit 10.4 AGREEMENT This Agreement (this “Agreement”), is made and entered into as of March 15 , 2024, by and between EUDA Health Holdings Limited, a British Virgin Islands company (the “Company”), and Meng Dong (James) Tan (“Mr. Tan”). WHEREAS, pursuant to the terms of loan agreement dated May 15, 2023 (the “Loan Agreement”), the Company borrowed the sum of US$22,500.00 from Mr. Tan (the “Orig |
|
| April 4, 2024 |
Exhibit 10.5 AGREEMENT This Agreement (this “Agreement”), is made and entered into as of March 1 5, 2024, by and between EUDA Health Holdings Limited, a British Virgin Islands company (the “Company”), and 8i Enterprises Pte Ltd (“8iEPL”). WHEREAS, pursuant to the terms of a series of loan agreements executed on May 15, 2023, May 18, 2023, May 22, 2023, August 5, 2023, August 29, 2023, September 4, |
|
| April 4, 2024 |
Exhibit 10.3 |
|
| April 4, 2024 |
Exhibit 10.6 NEITHER THIS NOTE, NOR THE SHARES UNDERLYING THIS NOTE, HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND THE SHARES UNDERLYING THIS NOTE MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE OF THE UNDERLYING SHARES THEREOF UNDER THE SECURITIES ACT OR AN OPINION |
|
| April 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 (Address o |
|
| April 4, 2024 |
Exhibit 10.1 |
|
| March 27, 2024 |
EUDA / EUDA Health Holdings Limited / Tan Meng Dong Passive Investment SC 13G 1 formsc13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 EUDA HEALTH HOLDINGS LIMITED (Name of Issuer) ORDINARY SHARES, NO PAR VALUE (Title of Class of Securities) G3142E105 (CUSIP Number) DECEMB |
|
| March 5, 2024 |
AMENDMENT NO. 1 TO CONVERTIBLE PROMISSORY NOTE Exhibit 10.1 AMENDMENT NO. 1 TO CONVERTIBLE PROMISSORY NOTE This First Amendment (the “Amendment”) to the convertible promissory note of EUDA Health Holdings Limited, Inc. (the “Company”), dated November 17, 2022 (the “Note”) is made and entered into as of February 29, 2024 by and between the Company and the Holder, Maxim Group LLC (“Maxim”). The Company and Maxim are herein collectively referred |
|
| March 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 (Addres |
|
| February 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 (Addres |
|
| January 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 (Address |
|
| January 23, 2024 |
Exhibit 10.1 THIS CONVERTIBLE LOAN AGREEMENT is made the 16th day of January 2024. Between:- (1) Gilandi Limited, a company incorporated in the British Virgin Islands and having its registered office at Suite 30C, 30/F Morrision Plaza, 5-9 Morrison hill road, Wan Chai Hong Kong island, Hong kong (“the Lender”); and (2) Euda Health Holdings Limited, a company incorporated in the British Virgin Isla |
|
| January 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 (Address |
|
| January 17, 2024 |
Exhibit 99.2 EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements After receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency Singapore. January 16, 2024 (Globe Newswire) - As previously disclosed, EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice from Nasdaq on January 9, 2024 indicating |
|
| January 17, 2024 |
Exhibit 99.1 EUDA Health Holdings Limited Has Received Nasdaq Notification Regarding Minimum Market Value Deficiency Singapore. January 16, 2024 (Globe Newswire) - EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice (the “MVLS Notice”) from Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) on January 9, 2024 indicating that the Company had failed |
|
| December 29, 2023 |
Exhibit 99.2 OPERATING AND FINANCIAL REVIEW AND PROSPECTS IN CONNECTION WITH THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2023 AND 2022 In this report, as used herein, and unless the context suggests otherwise, the terms “EUDA,” “Company,” “we,” “us” or “our” refer to the combined business of Euda Health Holdings Limited and its subsidiaries a |
|
| December 29, 2023 |
EUDA HEALTH HOLDINGS LIMITED AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS Exhibit 99.1 EUDA HEALTH HOLDINGS LIMITED AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS June 30, 2023 December 31, 2022 (Unaudited) ASSETS CURRENT ASSETS Cash $ 320,486 $ 143,024 Restricted cash - 641,461 Accounts receivable, net 880,226 1,851,503 Other receivables 20,261 7,467 Due from related parties - 267,863 Prepaid expenses and other current assets 250,941 222,633 Forward p |
|
| December 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 (Addres |
|
| September 22, 2023 |
Filed pursuant to Rule 424(b)(3) Registration No. 333-268994 EUDA Health Holdings Limited 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 +65 6268 6821 22,439,888 Ordinary Shares 4,458,625 Ordinary Shares Issuable Upon the Exercise of Warrants 1,120,299 Ordinary Shares Issuable upon Conversion of $2,413,125 principal amount of Convertible Notes 292,250 Warrants to Purchase Ordinary Shares Th |
|
| September 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 (Addre |
|
| September 19, 2023 |
EUDA HEALTH HOLDINGS LIMITED 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 EUDA HEALTH HOLDINGS LIMITED 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 September 19, 2023 VIA EDGAR Mr. |
|
| September 8, 2023 |
As filed with the Securities and Exchange Commission on September 8, 2023 As filed with the Securities and Exchange Commission on September 8, 2023 Registration No. |
|
| September 8, 2023 |
Exhibit 107 Calculation of Filing Fee Tables FORM F-1 (Form Type) EUDA HEALTH HOLDINGS LIMITED (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered (1)(2) Proposed Maximum Offering Price Per Security Maximum Aggregate Offering Price (1)(2) Amount of Registration Fee Fees Previously Paid Equity Warrants to purchase ordinary shares Rule 457(a); Rule 457(i) 292,250 $ 11. |
|
| September 8, 2023 |
345 Park Avenue New York, NY 10154-1895 Direct 212.407.4000 Main 212.407.4000 Fax 212.407.4990 September 8, 2023 United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Attn: Conlon Danberg and Jane Park Re: EUDA Health Holdings Limited Amendment No. 1 to Registration Statement on Form |
|
| September 1, 2023 |
United States securities and exchange commission logo August 31, 2023 Wei Wen Kelvin Chen Chief Executive Officer EUDA Health Holdings Limited 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 Re: EUDA Health Holdings Limited Amendment No. |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 (Address |
|
| August 4, 2023 |
As filed with the Securities and Exchange Commission on August 4, 2023 As filed with the Securities and Exchange Commission on August 4, 2023 Registration No. |
|
| August 4, 2023 |
345 Park Avenue New York, NY 10154-1895 Direct 212.407.4000 Main 212.407.4000 Fax 212.407.4990 August 4, 2023 United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Attn: Jane Park Re: EUDA Health Holdings Limited Registration Statement on Form S-1 Filed December 23, 2022 File No. 333 |
|
| August 4, 2023 |
Exhibit 107 Calculation of Filing Fee Tables FORM F-1 (Form Type) EUDA HEALTH HOLDINGS LIMITED (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered (1)(2) Proposed Maximum Offering Price Per Security Maximum Aggregate Offering Price (1)(2) Amount of Registration Fee Fees Previously Paid Equity Warrants to purchase ordinary shares Rule 457(a); Rule 457(i) 292,250 $ 11. |
|
| August 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 (Address of |
|
| July 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40678 EUDA HEALTH HOLDINGS |
|
| July 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File Number: 001-40678 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 (Address of |
|
| June 28, 2023 |
Exhibit 21.1 Subsidiaries of EUDA Health Holdings Limited EUDA Doctor Private Limited, A Singapore company EUDA Health Limited, A British Virgin Islands company EUDA Private Limited, A Singapore company Kent Ridge Health Limited, A British Virgin Islands company Kent Ridge Healthcare Singapore Pte. Ltd., A Singapore company Kent Ridge Hill Private Limited, A Singapore company KR Digital Pte. Ltd., |
|
| June 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40678 EUDA HEALTH HOLDINGS LIMI |
|
| June 28, 2023 |
Description of Registered Securities. Exhibit 4.5 DESCRIPTION OF THE COMPANY’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED General The authorized capital stock of the Company consists of an unlimited number of shares of a single class, each with no par value. No preferred shares are issued or outstanding or authorized by the Company’s Charter. Ordinary Shares The Company’s shareholde |
|
| June 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2023 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 001-40678 n/a (State or other jurisdiction (Commission (I.R.S. |
|
| June 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2023 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 001-40678 n/a (State or other jurisdiction (Commission (I.R.S. |
|
| June 9, 2023 |
Exhibit 10.2 |
|
| June 9, 2023 |
EX-10.1 2 ex10-1.htm Exhibit 10.1 |
|
| June 9, 2023 |
Exhibit 10.3 |
|
| May 26, 2023 |
Settlement Agreement with 8i Holdings 2 Pte Ltd., dated May 16, 2023 Exhibit 10.2 |
|
| May 26, 2023 |
Settlement Agreement with Shine Link Limited, dated May 16, 2023 Exhibit 10.3 |
|
| May 26, 2023 |
Settlement Agreement with Mr. Meng Dong (James) Tan, dated May 16, 2023 Exhibit 10.1 |
|
| May 26, 2023 |
Settlement Agreement with Menora Capital Pte Ltd, dated May 16, 2023 Exhibit 10.4 |
|
| May 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2023 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 001-40678 n/a (State or other jurisdiction (Commission (I.R.S. |
|
| May 26, 2023 |
VGG3142E1051 / EUDA HEALTH HOLDINGS LTD / Tan Meng Dong Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 1) Under the Securities Exchange Act of 1934 EUDA Health Holdings Limited (Name of Company) Ordinary Shares, no par value (Title of Class of Securities) G3142E105 (CUSIP) Wei Wen Kelvin Chen Chief Executive Officer c/o 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 Tel: +65-6268 6821 (Name, |
|
| May 26, 2023 |
Form of Registration Rights Agreement, dated May 16, 2023 Exhibit 10.6 Registration Rights Agreement This Registration Rights Agreement (this “Agreement”) is made and entered into as of [●], 2023, between EUDA Health Holdings Limited, a British Virgin Islands business company (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”). This Agreement is made pursuant to the |
|
| May 26, 2023 |
Settlement Agreement with Kelvin Chen, dated May 16, 2023 Exhibit 10.5 |
|
| May 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2023 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 001-40678 n/a (State or other jurisdiction (Commission (I.R.S. |
|
| May 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2023 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 001-40678 n/a (State or other jurisdiction (Commission (I.R.S. |
|
| May 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 18, 2023 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 001-40678 n/a (State or other jurisdiction of incorporation) ( |
|
| May 19, 2023 |
EUDA Health Holdings Limited Announces Receipt of Nasdaq Listing Delinquency Letter Exhibit 99.1 EUDA Health Holdings Limited Announces Receipt of Nasdaq Listing Delinquency Letter Singapore, May 19, 2023 – EUDA Health Holdings Limited (the “Company” or “EUDA”) (NASDAQ: EUDA, EUDAW), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, announced today that it received a delinquency notification letter (“Notice |
|
| May 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 001-40678 CUSIP NUMBER G3142E105 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transi |
|
| May 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2023 (May 11, 2023) EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 001-40678 n/a (State or other jurisdiction of i |
|
| April 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 2023 (April 5, 2023) EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 001-40678 n/a (State or other jurisdiction of |
|
| April 10, 2023 |
EUDA Health Holdings Limited Announces Receipt of Nasdaq Listing Delinquency Letter Exhibit 99.1 EUDA Health Holdings Limited Announces Receipt of Nasdaq Listing Delinquency Letter Singapore, April 10, 2023 – EUDA Health Holdings Limited (the “Company” or “EUDA”) (NASDAQ: EUDA, EUDAW), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, announced today that it received a delinquency notification letter (“Noti |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-SAR For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form. |
|
| March 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2023 (March 12, 2023) EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 001-40678 n/a (State or other jurisdiction o |
|
| March 15, 2023 |
Acceptance Letter of Mr. Lew Chern Yong (Eric), effective March 12, 2023. Exhibit 99.1 |
|
| March 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2023 (March 1, 2023) EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 001-40678 n/a (State or other jurisdiction of |
|
| March 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2023 (February 23, 2023) EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 001-40678 n/a (State or other jurisdiction |
|
| February 17, 2023 |
EUDA HEALTH HOLDINGS LIMITED Board of Director Officer Letter Exhibit 99.1 EUDA HEALTH HOLDINGS LIMITED Board of Director Officer Letter February 15, 2023 Mr. Chee Hyong Leonard Chia On behalf of the board of the directors (the “Board”) of EUDA Health Holdings Limited, a British Virgin Islands business company (the “Company”), I am pleased to invite you to join the Board of Directors. You will serve as a Class II director from the date of acceptance indicate |
|
| February 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2023 (February 15, 2023) EUDA Health Holdings Limited (Exact name of registrant as specified in its charter) British Virgin Islands 001-40678 n/a (State or other jurisdic |
|
| February 14, 2023 |
EUDA / Euda Health Holdings Limited / Ayrton Capital LLC Passive Investment SC 13G/A 1 formsc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* EUDA HEALTH HOLDINGS LIMITED (Name of Issuer) Ordinary Shares, no par value (Title of Class of Securities) G3142E105 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate bo |
|
| February 14, 2023 |
Joint Filing Statement Statement Pursuant to Rule 13d-1(k)(1) EX-1 2 ex1.htm Exhibit 1 Joint Filing Statement Statement Pursuant to Rule 13d-1(k)(1) The undersigned hereby consent and agree to file a joint statement on Schedule 13G under the Securities Exchange Act of 1934, as amended, with respect to the Ordinary Shares, no par value, of EUDA Health Holdings Limited, beneficially owned by them, together with any or all amendments thereto, when and if approp |
|
| February 7, 2023 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* EUDA Health Holdings Limited (f/k/a 8i Acquisition 2 Corp.) (Name of Issuer) Ordinary Shares, no par value (Title of Class of Securities) G3142E105 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| January 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2023 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 001-40678 n/a (State or other jurisdiction of incorporatio |
|
| January 4, 2023 |
United States securities and exchange commission logo January 4, 2023 Wei Wen Kelvin Chen Chief Executive Officer EUDA Health Holdings Limited 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 Re: EUDA Health Holdings Limited Registration Statement on Form S-1 Filed December 23, 2022 File No. |
|
| December 23, 2022 |
Exhibit 10.4 LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this “Agreement”) is dated as of , 2022 by and between Watermark Developments Limited, a British Virgin Islands Company (the “Holder”) and 8i Acquisition 2 Corp., a British Virgin Islands company (the “Parent”). A. Parent, the Holder, Euda Health Limited, British Virgin Islands company (the “Company”) and , entered into a Stock Purchase Agreem |
|
| December 23, 2022 |
EX-2.1 5 ex2-4.htm Exhibit 2.4 AMENDMENT NO. 3 TO THE SHARE PURCHASE AGREEMENT This Amendment No. 3 to the Share Purchase Agreement (this “Amendment”) is made as of September 7, 2022, by and among Euda Health Limited, a British Virgin Islands business company (the “Company”), Watermark Developments Limited, a British Virgin Islands business company (“Seller”), and 8i Acquisition 2 Corp., a British |
|
| December 23, 2022 |
Form of Amended and Restated Registration Rights Agreement Exhibit 10.1 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), effective as of the [●] day of [●], 2022 (the “Effective Date”), is made and entered into by and among (i) 8i Acquisition 2 Corp., a British Virgin Islands company (the “Company”), (ii) each of the undersigned parties that are Pre-BC Investors (as defined belo |
|
| December 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form S-1 Registration Statement Under The Securities Act of 1933 EUDA HEALTH HOLDINGS LIMITED (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 8000 n/a (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identific |
|
| December 23, 2022 |
Form of First Amendment to Amended and Restated Registration Rights Agreement Exhibit 10.2 First Amendment to Amended and Restated Registration Rights Agreement This First Amendment to the Amended and Restated Registration Rights Agreement (this “Amendment”), dated as of November 30, 2022, is made and entered into by and among EUDA Health Holdings Limited (formerly known as 8i Acquisition 2 Corp.), a British Virgin Islands business company (the “Company”), and each of the u |
|
| December 23, 2022 |
Form of Indemnification Agreement Exhibit 10.3 INDEMNIFICATION AGREEMENT This Indemnification Agreement (“Agreement”) is made as of November 17, 2022, by and between EUDA Health Holdings Limited, a British Virgin Islands business company (the “Company”), and a member of the board of directors and/or officer of the Company, as applicable (“Indemnitee”). This Agreement supersedes and replaces any and all previous Agreements between |
|
| December 23, 2022 |
Letter from UHY LLP to the SEC, dated November 23, 2022 EX-16.1 16 ex16-1.htm Exhibit 16.1 1185 Avenue of the Americas, 38th Floor New York, NY 10036-2603 Phone 212-381-4800 Fax 212-381-4811 Web www.uhy-us.com November 23, 2022 Office of the Chief Accountant Securities and Exchange Commission 460 Fifth Street N. W. Washington, DC 20549 Re: EUDA Health Holdings Limited Ladies and Gentlemen: We have read Item 4.01 of Form 8-K filed with the U.S. Securiti |
|
| December 23, 2022 |
EX-FILING FEES 20 ex107.htm Exhibit 107 Calculation of Filing Fee Tables FORM S-1 (Form Type) EUDA HEALTH HOLDINGS LIMITED (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered (1)(2) Proposed Maximum Offering Price Per Security Maximum Aggregate Offeri |
|
| December 23, 2022 |
Exhibit 21.1 Subsidiaries of EUDA Health Holdings Limited EUDA Doctor Private Limited, A Singapore company EUDA Health Limited, A British Virgin Islands company EUDA Private Limited, A Singapore company Kent Ridge Health Limited, A British Virgin Islands company Kent Ridge Healthcare Singapore Pte. Ltd., A Singapore company Kent Ridge Hill Private Limited, A Singapore company KR Digital Pte. Ltd., |
|
| December 23, 2022 |
Exhibit 4.2 FORM OF WARRANT AGREEMENT BETWEEN American Stock Transfer & Trust Company, LLC AND THE REGISTRANT WARRANT AGREEMENT This Warrant Agreement (“Warrant Agreement”) is made as of [*], 2021, by and between 8i Acquisition 2 Corp., a British Virgin Islands company (the “Company”), and American Stock Transfer & Trust Company, LLC (the “Warrant Agent”). WHEREAS, the Company is engaged in a publ |
|
| December 23, 2022 |
Specimen Ordinary Share Certificate of EUDA Health Holdings Limited Exhibit 4.3 |
|
| December 23, 2022 |
EX-2.1 2 ex2-1.htm Exhibit 2.1 SHARE PURCHASE AGREEMENT by and among EUDA HEALTH LIMITED, WATERMARK DEVELOPMENTS LIMITED, 8I ACQUISITION 2 CORP., and Kwong Yeow Liew Dated as of April 11, 2022 TABLE OF CONTENTS Page Article I Purchase 2 1.1 Purchase and Sale of Shares 2 1.2 Purchase Price 2 1.3 Payment of Expenses 2 1.4 Indemnification Escrow Shares 2 1.5 Closing Statements 2 1.6 Earn-Out 3 Articl |
|
| December 23, 2022 |
Exhibit 4.1 SPECIMEN WARRANT CERTIFICATE NUMBER WA- [ ] WARRANTS (THIS WARRANT WILL BE VOID IF NOT EXERCISED PRIOR TO 5:00 P.M. NEW YORK CITY TIME, FIVE YEARS FROM THE CLOSING DATE OF THE COMPANY’S INITIAL BUSINESS COMBINATION) 8i ACQUISITION 2 CORP. CUSIP WARRANT THIS WARRANT CERTIFIES THAT, for value received , or registered agents, is the registered holder of a Warrant or Warrants (the “Warrant |
|
| December 23, 2022 |
Exhibit 2.3 AMENDMENT NO. 2 TO THE SHARE PURCHASE AGREEMENT This Amendment No. 2 to the Share Purchase Agreement (this “Amendment”) is made as of June 10, 2022, by and among Euda Health Limited, a British Virgin Islands business company (the “Company”), Watermark Developments Limited, a British Virgin Islands business company (“Seller”), and 8i Acquisition 2 Corp., a British Virgin Islands busines |
|
| December 23, 2022 |
Exhibit 10.5 SELLER RELEASE This Seller Release (this “Release”) is dated as of this day of April, 2022, by and among Watermark Developments Limited, a British Virgin Islands corporation (the “Releasing Party”), in its capacity as the sole stockholder of Euda Health Limited, a British Virgin Islands corporation (the “Company”), the Company, and 8i Acquisition 2 Corp., a British Virgin Islands corp |
|
| December 23, 2022 |
Exhibit 2.2 AMENDMENT NO. 1 TO THE SHARE PURCHASE AGREEMENT This Amendment No. 1 to the Share Purchase Agreement (this “Amendment”) is made as of May 30, 2022, by and among Euda Health Limited, a British Virgin Islands business company (the “Company”), Watermark Developments Limited, a British Virgin Islands business company (“Seller”), and 8i Acquisition 2 Corp., a British Virgin Islands business |
|
| December 23, 2022 |
Amended and Restated Memorandum and Articles of Association of EUDA Health Holdings Limited Exhibit 3.1 |
|
| December 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) * 8i Acquisition 2 Corp. (Name of Issuer) Common (Title of Class of Securities) G2956R103 (CUSIP Number) November 30, 2022 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| November 25, 2022 |
EUDA / Euda Health Holdings Limited / Watermark Developments Ltd Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 EUDA Health Holdings Limited (Name of Company) Ordinary Shares, no par value (Title of Class of Securities) G3142E105 (CUSIP) Wei Wen Kelvin Chen Chief Executive Officer 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 Tel: +65-6268 6821 (Name, Address and Telephone N |
|
| November 25, 2022 |
EUDA / Euda Health Holdings Limited / Tan Meng Dong Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 EUDA Health Holdings Limited (Name of Company) Ordinary Shares, no par value (Title of Class of Securities) G3142E105 (CUSIP) Wei Wen Kelvin Chen Chief Executive Officer c/o 1 Pemimpin Drive #12-07 One Pemimpin Singapore 576151 Tel: +65-6268 6821 (Name, Address and Telepho |
|
| November 23, 2022 |
Letter from UHY LLP to the SEC, dated November 23, 2022 Exhibit 16.1 1185 Avenue of the Americas, 38th Floor New York, NY 10036-2603 Phone 212-381-4800 Fax 212-381-4811 Web www.uhy-us.com November 23, 2022 Office of the Chief Accountant Securities and Exchange Commission 460 Fifth Street N. W. Washington, DC 20549 Re: EUDA Health Holdings Limited Ladies and Gentlemen: We have read Item 4.01 of Form 8-K filed with the U.S. Securities and Exchange Commis |
|
| November 23, 2022 |
Exhibit 21.1 Subsidiaries of EUDA Health Holdings Limited EUDA Doctor Private Limited, A Singapore company EUDA Health Limited, A British Virgin Islands company EUDA Private Limited, A Singapore company Kent Ridge Health Limited, A British Virgin Islands company Kent Ridge Healthcare Singapore Pte. Ltd., A Singapore company Kent Ridge Hill Private Limited, A Singapore company KR Digital Pte. Ltd., |
|
| November 23, 2022 |
EUDA / Euda Health Holdings Limited / Ayrton Capital LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| November 23, 2022 |
8i Acquisition 2 Corp. and EUDA Health Limited Complete Business Combination Exhibit 99.4 8i Acquisition 2 Corp. and EUDA Health Limited Complete Business Combination Singapore, November 17, 2022 ? 8i Acquisition 2 Corp. (the ?Company? or ?LAX?) (NASDAQ: LAX), a publicly traded special purpose acquisition company, today announced the completion of its business combination (the ?Business Combination?) with EUDA Health Limited (?EUDA Health?), a Singapore-based digital healt |
|
| November 23, 2022 |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF EUDA Exhibit 99.2 MANAGEMENT?S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF EUDA You should read the following discussion and analysis of Euda Health Limited (?EUDA?)?s financial condition and results of operations in conjunction with its audited condensed consolidated financial statements and the notes related thereto which are included elsewhere in the Current Report on |
|
| November 23, 2022 |
Form of Indemnification Agreement Exhibit 10.2 INDEMNIFICATION AGREEMENT This Indemnification Agreement (?Agreement?) is made as of November 17, 2022, by and between EUDA Health Holdings Limited, a British Virgin Islands business company (the ?Company?), and a member of the board of directors and/or officer of the Company, as applicable (?Indemnitee?). This Agreement supersedes and replaces any and all previous Agreements between |
|
| November 23, 2022 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The following unaudited pro forma condensed combined financial information present the combination of the financial information of 8i and EUDA adjusted to give effect to the Business Combination. The following unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regu |
|
| November 23, 2022 |
Specimen Ordinary Share Certificate of EUDA Health Holdings Limited Exhibit 4.3 |
|
| November 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2022 EUDA Health Holdings Limited (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 001-40678 n/a (State or other jurisdiction of ?incorporati |
|
| November 23, 2022 |
Euda Health Limited and Subsidiaries Index to Unaudited Condensed Consolidated Financial Statements EX-99.1 7 ex99-1.htm Exhibit 99.1 Euda Health Limited and Subsidiaries Index to Unaudited Condensed Consolidated Financial Statements Condensed Consolidated Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021 (Audited) 2 Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the Nine Months Ended September 30, 2022 and 2021 3 Unaudited C |
|
| November 23, 2022 |
Amended and Restated Memorandum and Articles of Association of EUDA Health Holdings Limited Exhibit 3.1 |
|
| November 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended October 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40678 EUDA HEALTH HOLDING |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2022 8i Acquisition 2 Corp. (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 001-40678 n/a (State or other jurisdiction of incorporation) (C |
|
| November 14, 2022 |
Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2022 8i Acquisition 2 Corp. (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 001-40678 n/a (State or other jurisdiction of ?incorporation) (C |
|
| November 14, 2022 |
Prepaid Forward Agreement, dated November 13, 2022 Exhibit 10.1 Date: November 13, 2022 To: 8i Acquisition 2 Corp., a British Virgin Islands business company (“8i”) and EUDA Health Limited, a British Virgin Islands business company (the “EUDA”). Address: 6 Eu Tong Sen Street #08-13 Singapore 059817 From: Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B (“Seller”) Re: OTC Equity Prepaid Forward Transaction The purpose of this agree |
|
| November 14, 2022 |
Prepaid Forward Agreement, dated November 13, 2022 Exhibit 10.1 Date: November 13, 2022 To: 8i Acquisition 2 Corp., a British Virgin Islands business company (?8i?) and EUDA Health Limited, a British Virgin Islands business company (the ?EUDA?). Address: 6 Eu Tong Sen Street #08-13 Singapore 059817 From: Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B (?Seller?) Re: OTC Equity Prepaid Forward Transaction The purpose of this agree |
|
| November 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2022 8i Acquisition 2 Corp. (Exact Name of Registrant as Specified in its Charter) British Virgin Islands 001-40678 n/a (State or other jurisdiction of ?incorporation) (Co |
|
| November 10, 2022 |
Prepaid Forward Agreement, dated November 9, 2022 Exhibit 10.1 Date: November 9, 2022 To: 8i Acquisition 2 Corp., a British Virgin Islands business company (?8i?) and EUDA Health Limited, a British Virgin Islands business company (the ?EUDA?). Address: 6 Eu Tong Sen Street #08-13 Singapore 059817 From: HB Strategies LLC (?Seller?) Re: OTC Equity Prepaid Forward Transaction The purpose of this agreement (this ?Confirmation?) is to confirm the term |
